XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

levocetirizine dihydrochloride, Quantity: 5 mg/mL

Mevcut itibaren:

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

INN (International Adı):

levocetirizine dihydrochloride

Farmasötik formu:

Oral Liquid

Kompozisyon:

Excipient Ingredients: purified water; propylene glycol; glycerol; acetic acid; saccharin sodium; methyl hydroxybenzoate; propyl hydroxybenzoate; sodium acetate

Uygulama yolu:

Oral

Paketteki üniteler:

1 x 15mL bottle, 1 x 20mL bottle, 1 x 10 mL bottle

Reçete türü:

(S2) Pharmacy Medicine

Terapötik endikasyonlar:

Xyzal oral drops are indicated for the symptomatic treatment of allergic rhinitis (including persistent rhinitis) and chronic idiopathic urticaria in adults and children aged 2 years and over.

Ürün özeti:

Visual Identification: Clear, colourless solution; Container Type: Bottle; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

2010-01-19